Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (25)

2023

  1. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE

    Journal of hypertension, Vol. 40, pp. e81

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

  3. Night-time heart rate cut-off point definition by resting office tachycardia in untreated hypertensive patients: Data of the Spanish ABPM registry

    Journal of Hypertension, Vol. 32, Núm. 5, pp. 1016-1024

2013

  1. Association between urinary albumin excretion and both central and peripheral blood pressure in subjects with insulin resistance

    Journal of Hypertension, Vol. 31, Núm. 1, pp. 103-108

  2. Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients

    Blood Pressure, Vol. 22, Núm. 1, pp. 39-44

2011

  1. New clinical concepts after the ONTARGET trial

    Expert Review of Cardiovascular Therapy, Vol. 9, Núm. 6, pp. 685-689

  2. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives

    Hypertension, Vol. 57, Núm. 3 PART 2, pp. 556-560

2009

  1. Knowledge and implementation of the new European guide in the management of arterial hypertension. The cigema survey

    Pharmaceuticals, Vol. 2, Núm. 2, pp. 11-32

2007

  1. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: A cross-sectional analysis of a 20 000-patient database in Spain

    Journal of Hypertension, Vol. 25, Núm. 5, pp. 977-984

2006

  1. Glucose metabolism in patients with essential hypertension

    American Journal of Medicine, Vol. 119, Núm. 4, pp. 318-326

  2. Metabolismo glucídico en la hipertensión arterial: Papel de la sobrecarga oral de la glucosa

    Medicina Clinica

2004

  1. Blood pressure control and physician physician management of hypertension in hospital hypertension units in Spain

    Hypertension, Vol. 43, Núm. 6, pp. 1338-1344

  2. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension

    Journal of Hypertension

  3. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: Results of a Spanish national study

    American Journal of Hypertension, Vol. 17, Núm. 2, pp. 139-145

2003

  1. Efecto del tratamiento antihipertensivo con irbesartán sobre el riesgo cardiovascular absoluto

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 183-188

2002

  1. Hypertension magnitude and management in the elderly population of Spain

    Journal of Hypertension, Vol. 20, Núm. 11, pp. 2157-2164

2001

  1. Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 40-44

2000

  1. Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits

    General Pharmacology: The Vascular System, Vol. 34, Núm. 4, pp. 263-272